Insider Buying: Hims & Hers Health, Inc. (NYSE:HIMS) Director Buys 1,000 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS) Director Anja Manuel bought 1,000 shares of the stock in a transaction dated Thursday, November 14th. The stock was bought at an average price of $24.50 per share, with a total value of $24,500.00. Following the acquisition, the director now owns 5,000 shares in the company, valued at approximately $122,500. This represents a 25.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Anja Manuel also recently made the following trade(s):

• On Tuesday, November 12th, Anja Manuel acquired 4,000 shares of Hims & Hers Health stock. The shares were purchased at an average cost of $26.94 per share, for a total transaction of $107,760.00.

Hims & Hers Health Price Performance

Shares of HIMS stock traded down $6.76 on Thursday, hitting $20.85. 62,625,345 shares of the stock traded hands, compared to its average volume of 9,152,479. The company has a market capitalization of $4.48 billion, a PE ratio of 49.34 and a beta of 1.06. The company’s fifty day moving average is $19.51 and its 200 day moving average is $18.77. Hims & Hers Health, Inc. has a 1-year low of $7.40 and a 1-year high of $30.44.

Hims & Hers Health (NYSE:HIMS) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business had revenue of $401.56 million for the quarter, compared to analysts’ expectations of $382.20 million. During the same period in the prior year, the firm earned ($0.04) EPS. The business’s quarterly revenue was up 77.1% on a year-over-year basis. As a group, equities research analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Needham & Company LLC assumed coverage on shares of Hims & Hers Health in a research note on Thursday, August 22nd. They issued a “buy” rating and a $24.00 price objective on the stock. TD Cowen increased their price target on shares of Hims & Hers Health from $25.00 to $28.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Imperial Capital downgraded shares of Hims & Hers Health from an “outperform” rating to an “in-line” rating in a report on Friday, August 9th. Bank of America cut Hims & Hers Health from a “buy” rating to an “underperform” rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $21.21.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of HIMS. Renaissance Technologies LLC raised its position in shares of Hims & Hers Health by 113.1% during the second quarter. Renaissance Technologies LLC now owns 6,039,408 shares of the company’s stock worth $121,936,000 after purchasing an additional 3,205,108 shares during the period. Farallon Capital Management LLC grew its holdings in shares of Hims & Hers Health by 3,890.5% during the first quarter. Farallon Capital Management LLC now owns 1,676,000 shares of the company’s stock valued at $25,928,000 after buying an additional 1,634,000 shares in the last quarter. M&G Plc acquired a new position in Hims & Hers Health during the first quarter valued at $8,232,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Hims & Hers Health by 164.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 528,142 shares of the company’s stock valued at $10,663,000 after buying an additional 328,142 shares during the period. Finally, State of Michigan Retirement System raised its position in Hims & Hers Health by 177.8% during the second quarter. State of Michigan Retirement System now owns 500,000 shares of the company’s stock valued at $10,095,000 after acquiring an additional 320,000 shares in the last quarter. Institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.